ABSTRACT A 2.6-kilobase (kb) EcoRI restriction endonuclease fragment containing human growth hormone (hGH; somatotropin) gene sequences and a 2.8-kb EcoRI fragment containing human chorionic somatomammotropin (hCS; choriomammotropin) gene sequences have been identified by hybridization to cloned cDNA. Human DNA was cleaved with EcoRI and fractionated by preparative agarose gel electrophoresis; DNA in the size range 2-3 kb was ligated to Xgt WES'XB DNA and viable recombinant bacteriophage were recovered by in vitro packaging. After infection of Escherichia coli and screening of phage plaques, single isolates of hGH and hCS gene sequences were obtained. Restriction endonuclease mapping showed that the hGH gene contains three intervening sequences interrupting the coding sequence. Partial DNA sequence analysis of the hGH gene, obtained by the chain termination method, confirmed the location of the intervening sequences and the identity of the fragment. Human growth hormone (hGH) and human chorionic somatomammotropin (hCS) are two closely related polypeptide hormones which have more than 80% of their 191 amino acids in common (1, 2). They have different biological activities and are synthesized in different tissues: hGH in the pituitary and hCS in the placenta. The genes coding for these two hormones provide a good system for studying the organization of structurally related sequences and their tissue-specific expression.
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A 550-base-pair Hae III fragment cDNA clone coding for amino acids of the hCS sequence has been described (3) . Recently, the analogous 550-base-pair Hae III fragment coding for hGH has also been cloned and its nucleotide sequence has been determined (unpublished data). The nucleotide sequences of these two fragments are 93% homologous.
Further analysis of this system requires the isolation of genomic DNA fragments that contain the entire coding sequences and the regulating elements that may be involved in the differential expression of the genes. This report describes the construction of genomic DNA clones for sequences of both the hGH and hCS genes by utilizing bacteriophage Xgt WES-XB as the vector (4) and the bacteriophage X in vitro packaging system of Blattner et al. (5) .
MATERIALS AND METHODS
Human Placental DNA. High molecular weight DNA was extracted from human placenta obtained by caesarian section. The frozen tissue was dispersed in a blender, treated with proteinase K, extracted with phenol/chloroform, and then incubated sequentially with RNase A and proteinase K (6). After extraction with phenol/chloroform, the DNA was precipitated with ethanol.
Preparative Agarose Gel Electrophoresis. EcoRI-digested human placental DNA (17.5 mg) was fractionated on a continuous elution, horizontal, 0.8% agarose gel, essentially as described by Polsky et al. (6) except that Seakem HGT (P) agarose was used because this appeared to contain fewer contaminants that inhibit subsequent enzymatic steps. The DNA was collected in approximately 80 fractions, and aliquots of these were assayed by analytical agarose gel electrophoresis followed by filter hybridization to a radioactive hGH cDNA probe.
Filter Hybridization. The filter hybridization technique of Southern (7) (13) except that the filters were pre-wetted with water and then 6-fold concentrated NaCl/Cit before application to the petri dish for 4 min; denaturation was for 4 min in 0.2 M NaOH/1.5 M NaCl; neutralization was for 4 min in 0.5 M Tris, pH 7.5/3 M NaCl, followed by a brief wash in 2-fold concentrated NaCl/Cit. The filters were hybridized to the hGH cDNA probe as described above.
DNA Sequence Analysis. The chain termination method (14) was used with single-stranded template DNA generated a unique Xba I site. The fact that the 2.6-kb fragment contained a Bgl II but no Xba I site whereas the 2.8-kb fragment had an Xba I but no Bgl II site supports the identification of the fragments given above. Isolation and Identification of Recombinant DNA Containing hGH and hCS Gene Sequences. In vitro packaging systems in which bacteriophage X DNA is ligated to exogenous DNA and used to generate mature infective phage particles have been described (5, (17) (18) (19) . The DNA packaged into phage can be used to infect E. coli with a considerably higher efficiency than is obtained by transfection with the DNA itself. In the experiments described here, the in vitro packaging system of Blattner et al. (5) (Fig. 3A) that was identical to that observed in total human DNA (Fig. 2) . Similarly, the digestion pattern of the 2.8-kb hCS fragment (Fig. 3B) (15) . An autoradiograph of a sequencing gel is shown in Fig.  5 and the sequence of the junction between the coding and intervening sequence is shown in Fig. 6 
Autoradiograph of an 8% polyacrylamide DNA sequencing gel used in the chain termination method with 2'3'-dideoxy ATP, 2'3'-dideoxy CTP, 2'3'-dideoxy GTP, and 2'3'-dideoxy TTP as chain-terminating analogues. The primer was a 29-nucleotide-long fragment obtained by digestion of the cloned 550-base-pair cDNA fragment of hGH with Pst I and Hinfl. The template was prepared by treating HindIII-cut pBR322-ghGH(2.6) with E. coli exonuclease III. The sequence read from the gel is written adjacent to the autoradiograph with the complementary sense strand (+) written alongside that. The arrows indicate the two possible splice points, and the asterisk marks the codon that differs from the cDNA. (Fig. 4) has been obtained by a similar strategy (data not shown), thus confirming the existence of a second intervening sequence in the hGH gene.
An 800-base-pair "full-length" cDNA clone of hGH (chGH 800) has been obtained recently (20) . This contains, in addition to the entire coding sequence, 29 nucleotides of the 5' untranslated region and all 109 nucleotides of the 3' untranslated region preceding the poly(A) sequence. When this 800base-pair fragment is used as a hybridization probe with pBR322-ghGH(2.6), the PstI/Pvu II fragment between positions 600 and 1000 hybridizes strongly. T6is fragment does not hybridize to the chGH 550 probe, thus indicating that a large portion of the 5' end of the hGH gene is contained in this region (Fig. 4) . A very low level of hybridization of the chGH 800 probe to the 5'-terminal EcoRI/Pst I fragment has also been detected, indicating the possibility of a third intervening sequence (A) in the hGH gene. This will require further DNA sequence analysis for confirmation.
DNA sequence analysis has also established that the 2.6-kb hGH fragment contains the poly(A) addition site (Fig. 4) . (Fig. 4) derived for the hGH gene indicates that, in common with other eukaryotic genes (22) (23) (24) (25) (26) , the hGH gene contains intervening sequences that interrupt the coding sequences.
One of the two identified intervening sequences (sequence B) is about 220 base pairs long; the other (sequence C) is about 300 base pairs. A third intervening sequence (sequence A) very close to the 5' end of the gene may also exist. The possibility that other very small intervening sequences are present-i.e., that some of the intervening sequences are interspersed within short coding regions-has not yet been excluded.
Preliminary DNA sequence analysis of the pBR322-ghGH(2.6) recombinant has confirmed the existence of the intervening regions shown in Fig. 4 . The sequence at the 3' end of intervening sequence B (at approximately position 1200) is shown in Figs. 5 and 6. As in other systems, the 3' end is marked by an A-G doublet (27) .
A detailed restriction enzyme map has not yet been determined for the hCS gene but the preliminary evidence suggests that the pattern of intervening sequences may be similar to that of the hGH gene. Total human placental DNA, when digested with both EcoRI and Pvu II (Fig. 2) , contains a single 980- base-pair fragment that hybridizes to the chGH 550 probe. This probe also detects hCS sequences. Because this fragment contains intervening and coding sequences in the hGH gene, the appearance of6a single band implies that the hCS gene may also contain a similar structure in this region.
Several nucleotide sequence differences have been detected between the ghGH(2.6) gene and the cloned cDNA fragment. One of these is shown in Fig. 6 : a CCA proline codon at amino acid position 37 in the cDNA is changed to a CTG leucine codon in the gene. The cDNA proline codon corresponds to the amino acid sequence established for the hGH protein (28) . This codon change is in a region where tryptic mapping data of the hGH protein indicates that amino acid sequence variants occur (29) . The ghGH(2.6) fragment may therefore correspond to an allelic variant of growth hormone. Alternatively, the differences may -be the result of the different sources of material used: the hGH cDNA came from a pool of pituitary tumors and the hGH gene came from a single placenta.
The amino acid data in Fig. 6 exclude the possibility that a growth hormone variant of molecular weight 20,000 (29) , rather than the normal 22,000, has been cloned. This variant, which exists as 5-10% of the total growth hormone, lacks the tryptic peptide located between amino acids 38 and 41. The DNA sequence analysis presented in Fig. 6 shows that the coding region corresponding to this peptide is present in ghGH(2.6). Nucleotide sequence differences between the cDNA and ghGH(2.6) have also been detected in the 3' untranslated region (unpublished data).
An independently isolated 2.6-kb fragment has been recently cloned (unpublished data). This fragment gives rise to an identical hybridization pattern as the first isolate when the enzymes Pvu II, Pst I, Bgl II, and Sma I arepused. However, a difference between the two is noticed with the enzyme Hae III. The possibility therefore exists that this second isolate corresponds to the expressed growth hormone gene. DNA sequence analysis of this isolate will be required in order to determine whether this is the case.
